(secondQuint)The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease.

 Prospective, multicenter, 2:1 randomized, cross-over, two arms - Control arm: Double-dose PPI [Omeprazole 20 mg BID (twice a day)] - Treatment arm: LINX Reflux Management System Up to 20 study centers throughout the U.

S.

 will participate.

 Approximately150 patients will be enrolled into the study.

 Subjects will be randomized 2:1 into the double-dose PPIs arm (100 subjects) and the LINX arm (50 subjects).

.

 The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease@highlight

This study compares mechanical sphincter augmentation (LINX Reflux Management System) to double-dose proton pump inhibitors (PPIs) for the management of reflux symptoms related to gastroesophageal reflux disease (GERD).

